More News

16 Nov 2020 Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases
12 Nov 2020 MorphoSys and Cherry Biolabs Announce licensing of Hemibody Technology
09 Nov 2020 Infinity Pharmaceuticals Presents New MARIO-1 Phase 1/1b Clinical Data at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
06 Nov 2020 OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis
06 Nov 2020 Artiva Biotherapeutics and Affimed Announce Platform-to-Platform R&D Collaboration for Targeted Off-the-Shelf NK Cell Therapies
06 Nov 2020 Novo Nordisk to acquire Emisphere Technologies and obtain ownership of the Eligen® SNAC oral delivery technology
05 Nov 2020 Merck to Acquire VelosBio
03 Nov 2020 Fusion Pharmaceuticals Announces Collaboration with AstraZeneca to Develop and Commercialize Next-Generation Radiopharmaceuticals and Combination Therapies
02 Nov 2020 Tempus Announces Strategic Collaboration With Janssen Applying Data Science to Enhance Therapeutic Development
02 Nov 2020 Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
29 Oct 2020 Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company
28 Oct 2020 insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover and Develop Novel Treatments for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
26 Oct 2020 AnaptysBio and GlaxoSmithKline Amend Strategic Immuno-Oncology Collaboration
23 Oct 2020 Arixa Pharmaceuticals Announces Acquisition by Pfizer’s Hospital Business
23 Oct 2020 Retrophin Announces Agreement to Acquire Orphan Technologies
19 Oct 2020 Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with Genentech
19 Oct 2020 Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo™
17 Oct 2020 Denali Therapeutics to Highlight Progress Across Broad Biotherapeutics Portfolio for Neurodegeneration Enabled by Its Blood-Brain Barrier (BBB) TV Platform at Virtual R&D Day Today
16 Oct 2020 XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure using PASylation Technology
15 Oct 2020 Lilly Announces Agreement to Acquire Disarm Therapeutics
14 Oct 2020 Boehringer Ingelheim and Oxford BioTherapeutics Expand Collaboration to Discover Novel Selective Tumor Targets as First Bispecific Antibody Advanced into the Clinic
14 Oct 2020 Dyno Therapeutics Enters Collaboration and License Agreement with Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
14 Oct 2020 Secarna Pharmaceuticals and Denali Therapeutics Enter Into Research and Option Agreement to Develop Novel Antisense Therapies in the Field of Neurodegenerative Diseases
13 Oct 2020 Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies
12 Oct 2020 HitGen to Acquire Vernalis, a Leader in Structure-Based Drug Discovery

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up